- Home
- ENSG vs CORT Comparison
ENSG vs CORT Comparison
Compare ENSG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSG
- CORT
- Stock Information
- Founded
- ENSG 1999
- CORT 1998
- Country
- ENSG United States
- CORT United States
- Employees
- ENSG N/A
- CORT N/A
- Industry
- ENSG Hospital/Nursing Management
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ENSG Health Care
- CORT Health Care
- Exchange
- ENSG Nasdaq
- CORT Nasdaq
- Market Cap
- ENSG 7.3B
- CORT 7.1B
- IPO Year
- ENSG 2007
- CORT N/A
- Fundamental
- Price
- ENSG $136.68
- CORT $70.23
- Analyst Decision
- ENSG Buy
- CORT Strong Buy
- Analyst Count
- ENSG 7
- CORT 4
- Target Price
- ENSG $164.71
- CORT $142.00
- AVG Volume (30 Days)
- ENSG 369.3K
- CORT 1.4M
- Earning Date
- ENSG 04-29-2025
- CORT 05-05-2025
- Dividend Yield
- ENSG 0.18%
- CORT N/A
- EPS Growth
- ENSG 39.72
- CORT 8.36
- EPS
- ENSG 5.30
- CORT 1.14
- Revenue
- ENSG $4,423,354,000.00
- CORT $685,446,000.00
- Revenue This Year
- ENSG $16.54
- CORT $36.81
- Revenue Next Year
- ENSG $9.20
- CORT $32.00
- P/E Ratio
- ENSG $25.90
- CORT $61.85
- Revenue Growth
- ENSG 14.81
- CORT 30.93
- 52 Week Low
- ENSG $115.79
- CORT $25.35
- 52 Week High
- ENSG $158.45
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- ENSG 64.69
- CORT 50.58
- Support Level
- ENSG $129.91
- CORT $68.92
- Resistance Level
- ENSG $133.08
- CORT $75.41
- Average True Range (ATR)
- ENSG 3.43
- CORT 3.76
- MACD
- ENSG 1.27
- CORT -0.19
- Stochastic Oscillator
- ENSG 95.87
- CORT 57.96
About ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.